Serum vitamin D levels are decreased in patients without remission of Graves' disease

Endocrine

Volumn 43, Issue 1, 2013, Pages 230-232

  Yasuda, Tetsuyuki ^a   Okamoto, Yasuyuki ^b   Hamada, Noboru ^b   Miyashita, Kazuyuki ^a   Takahara, Mitsuyoshi ^a   Sakamoto, Fumie ^a   Miyatsuka, Takeshi ^a   Kitamura, Tetsuhiro ^a   Katakami, Naoto ^a   Kawamori, Dan ^a   Otsuki, Michio ^a   Matsuoka, Taka Aki ^a   Kaneto, Hideaki ^a   Shimomura, Iichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Sumire Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; CALCIFEDIOL; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ADULT; ARTICLE; AUTUMN; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; DRUG WITHDRAWAL; EUTHYROIDISM; FEMALE; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REMISSION; SUMMER; TREATMENT DURATION; VITAMIN BLOOD LEVEL;

EID: 84872363585     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9789-6     Document Type: Article

References (12)

1. G.A. Brent, Clinical practice. Graves' disease. N. Engl. J. Med. 358(24), 2594-2605 (2008)
2. F. Baeke, T. Takiishi, H. Korf, C. Gysemans, C. Mathieu, Vitamin D: modulator of the immune system. Curr. Opin. Pharmacol. 10(4), 482-496 (2010)
3. G. Tamer, S. Arik, I. Tamer, D. Coksert, Relative vitamin D insufficiency in Hashimoto's thyroiditis. Thyroid 21(8), 891-896 (2011)
4. T. Yasuda, Y. Okamoto, N. Hamada, K. Miyashita, M. Takahara, F. Sakamoto, T. Miyatsuka, T. Kitamura, N. Katakami, D. Kawamori, M. Otsuki, T. Matsuoka, H. Kaneto, I. Shimomura, Serum vitamin D levels are decreased and associated with thyroid volume in female patients with newly onset Graves' disease. Endocrine (2012). doi: 10.1007/s12020-012-9679-y
5. H. Pantazi, P.D. Papapetrou, Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism. J. Clin. Endocrinol. Metab. 85(3), 1099-1106 (2000)
6. N. Vilarrasa, J. Vendrell, J. Maravall, I. Elío, E. Solano, P. San José, I. García, N. Virgili, J. Soler, J.M. Go′mez, Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population? Endocrine 38(2), 235-242 (2010)
7. H. Zhou, C. Xu, M. Gu, Vitamin D receptor (VDR) gene polymorphisms and Graves' disease: a meta-analysis. Clin. Endocrinol. (Oxf.) 70(6), 938-945 (2009)
8. A. Kurylowicz, E. Ramos-Lopez, T. Bednarczuk, K. Badenhoop, Vitamin D-binding protein (DBP) gene polymorphism is associated with Graves' disease and the vitamin D status in a Polish population study. Exp. Clin. Endocrinol. Diabetes 114(6), 329-335 (2006)
9. A. Misharin, M. Hewison, C.R. Chen, V. Lagishetty, H.A. Aliesky, Y. Mizutori, B. Rapoport, S.M. McLachlan, Vitamin D deficiency modulates Graves' hyperthyroidism induced in BALB/c mice by thyrotropin receptor immunization. Endocrinology 150(2), 1051-1060 (2009)
10. E. Borgogni, E. Sarchielli, M. Sottili, V. Santarlasci, L. Cosmi, S. Gelmini, A. Lombardi, G. Cantini, G. Perigli, M. Luconi, G.B. Vannelli, F. Annunziato, L. Adorini, M. Serio, C. Crescioli, Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells. Endocrinology 149(7), 3626-3634 (2008)
11. A. Antonelli, M. Rotondi, P. Fallahi, P. Romagnani, S.M. Ferrari, L. Barani, E. Ferrannini, M. Serio, Increase of interferon-γ-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy. Clin. Endocrinol. (Oxf.) 64(2), 189-195 (2006)
12. M. Rotondi, L. Chiovato, The chemokine system as a therapeutic target in autoimmune thyroid diseases: a focus on the interferon-γ inducible chemokines and their receptor. Curr. Pharm. Des. 17(29), 3202-3216 (2011)